| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |